These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 38292061)

  • 41. ERBB2 is a potential diagnostic and prognostic biomarker in renal clear cell carcinoma.
    Gao WN; Chen LG; Bao LR; He N; Hu TL; Lai C; Xu RF; Wang XF; Wang JY; Zhao JR; Meng Y
    Sci Rep; 2024 Oct; 14(1):22775. PubMed ID: 39353993
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prognostic value and immunological role of BAIAP2L2 in liver hepatocellular carcinoma: A pan-cancer analysis.
    Han X; Long W; Liu Y; Xu J
    Front Surg; 2022; 9():985034. PubMed ID: 36338652
    [TBL] [Abstract][Full Text] [Related]  

  • 43. FAT2 mutation is associated with better prognosis and responsiveness to immunotherapy in uterine corpus endometrial carcinoma.
    Wang Z; Xing L; Huang Y; Han P
    Cancer Med; 2023 Feb; 12(3):3797-3811. PubMed ID: 36812126
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cross-talk between SIM2s and NFκB regulates cyclooxygenase 2 expression in breast cancer.
    Wyatt GL; Crump LS; Young CM; Wessells VM; McQueen CM; Wall SW; Gustafson TL; Fan YY; Chapkin RS; Porter WW; Lyons TR
    Breast Cancer Res; 2019 Nov; 21(1):131. PubMed ID: 31783895
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Multiple roles of single-minded 2 in esophageal squamous cell carcinoma and its clinical implications.
    Tamaoki M; Komatsuzaki R; Komatsu M; Minashi K; Aoyagi K; Nishimura T; Chiwaki F; Hiroki T; Daiko H; Morishita K; Sakai Y; Seno H; Chiba T; Muto M; Yoshida T; Sasaki H
    Cancer Sci; 2018 Apr; 109(4):1121-1134. PubMed ID: 29427302
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Reliable estrogen-related prognostic signature for uterine corpus endometrial carcinoma.
    Li M; Wang S; Huang H; Li L
    Comput Biol Chem; 2024 Dec; 113():108216. PubMed ID: 39326337
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Synaptotagmin-like protein 1 is a potential diagnostic and prognostic biomarker in endometrial cancer based on bioinformatics and experiments.
    Meijuan C; Meng X; Fang L; Qian W
    J Ovarian Res; 2023 Jan; 16(1):16. PubMed ID: 36653850
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mammaglobin B may be a prognostic biomarker of uterine corpus endometrial cancer.
    Li J; Xu W; Zhu Y
    Oncol Lett; 2020 Nov; 20(5):255. PubMed ID: 32994818
    [TBL] [Abstract][Full Text] [Related]  

  • 49. ASPM, CDC20, DLGAP5, BUB1B, CDCA8, and NCAPG May Serve as Diagnostic and Prognostic Biomarkers in Endometrial Carcinoma.
    Zhang Q; Wang Y; Xue F
    Genet Res (Camb); 2022; 2022():3217248. PubMed ID: 36186000
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Construction and verification of an endoplasmic reticulum stress-related prognostic model for endometrial cancer based on WGCNA and machine learning algorithms.
    Lin S; Wei C; Wei Y; Fan J
    Front Oncol; 2024; 14():1362891. PubMed ID: 38725627
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The landscape and prognostic value of immune characteristics in uterine corpus endometrial cancer.
    Liu W; Sun L; Zhang J; Song W; Li M; Wang H
    Biosci Rep; 2021 Apr; 41(4):. PubMed ID: 33782686
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Identification of an eight-m6A RNA methylation regulator prognostic signature of uterine corpus endometrial carcinoma based on bioinformatics analysis.
    Miao C; Fang X; Chen Y; Zhao Y; Guo Q
    Medicine (Baltimore); 2021 Dec; 100(49):e27689. PubMed ID: 34889221
    [TBL] [Abstract][Full Text] [Related]  

  • 53. System analysis of
    Situ Y; Gao R; Lei L; Deng L; Xu Q; Shao Z
    Int J Biol Markers; 2022 Jun; 37(2):158-169. PubMed ID: 35254116
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Solute Carrier Family 7 Member 11 (SLC7A11) is a Potential Prognostic Biomarker in Uterine Corpus Endometrial Carcinoma.
    Fang X; Zhang T; Chen Z
    Int J Gen Med; 2023; 16():481-497. PubMed ID: 36777097
    [TBL] [Abstract][Full Text] [Related]  

  • 55. PPP1R14B is a diagnostic prognostic marker in patients with uterine corpus endometrial carcinoma.
    He K; Wang T; Huang X; Yang Z; Wang Z; Zhang S; Sui X; Jiang J; Zhao L
    J Cell Mol Med; 2023 Mar; 27(6):846-863. PubMed ID: 36824011
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Development of an Oxidative Phosphorylation-Related and Immune Microenvironment Prognostic Signature in Uterine Corpus Endometrial Carcinoma.
    Liu J; Chen T; Yang M; Zhong Z; Ni S; Yang S; Shao F; Cai L; Bai J; Yu H
    Front Cell Dev Biol; 2021; 9():753004. PubMed ID: 34901000
    [No Abstract]   [Full Text] [Related]  

  • 57. RNA 5-Methylcytosine regulators are associated with cell adhesion and predict prognosis of endometrial cancer.
    Yang S; Luo Y; Zhou D; Xiang J; Xi X
    Transl Cancer Res; 2023 Oct; 12(10):2556-2571. PubMed ID: 37969377
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pan-cancer analysis of the disulfidptosis-related gene
    Zong Y; Zhu A; Liu P; Fu P; Li Y; Chen S; Gao X
    Heliyon; 2024 Jun; 10(11):e31875. PubMed ID: 38845861
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Integrated bioinformatics analysis and experimental validation reveals fatty acid metabolism-related prognostic signature and immune responses for uterine corpus endometrial carcinoma.
    Guo C; He Y; Chen L; Li Y; Wang Y; Bao Y; Zeng N; Jiang F; Zhou H; Zhang L
    Front Oncol; 2022; 12():1030246. PubMed ID: 36439473
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comprehensive Analysis of the Expression and Prognosis for MCM4 in Uterine Corpus Endometrial Carcinoma.
    Pei LP; Zhang YZ; Li GY; Sun JL
    Front Genet; 2022; 13():890591. PubMed ID: 35719366
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.